Cyclic strain stimulates monocyte chemotactic protein-1 mRNA expression in smooth muscle cells

J Cell Biochem. 1999 Dec;76(2):303-10. doi: 10.1002/(sici)1097-4644(20000201)76:2<303::aid-jcb13>3.3.co;2-5.

Abstract

Hemodynamic forces are important determinants for the formation of atherosclerotic plaques. The recruitment of circulating monocytes into the arterial wall is an important step during atherogenesis. Monocyte chemotactic protein-1 (MCP-1) has been shown to be a key factor for monocyte transmigration. This study examined the effects of cyclic strain on MCP-1 mRNA expression levels of cultured rat aortic smooth muscle cells. The MCP-1 mRNA levels of aortic smooth muscle cells first increased as the duration of cyclic strain increased, reaching the maximum at 6-12 h, maintained at high levels throughout the 48-h strain period. To explore signaling pathways mediating cyclic strain-stimulated MCP-1 mRNA expression, we examined the involvement of tyrosine kinase and protein kinase C (PKC). Tyrosine kinase inhibitors, genistein and tyrphostin 51, at 50 microM blocked cyclic strain-stimulated MCP-1 mRNA expression. Preincubation with a PKC activator, phorbol 12-myristate 13-acetate (PMA), 2 microM, for 24 h to downregulate PKC did not decrease cyclic strain-induced MCP-1 mRNA expression. A 6-h incubation with 0. 1 microM PMA to activate PKC, which stimulated MCP-1 expression when applied alone, abolished the stimulatory effects of cyclic strain. A specific PKC inhibitor, calphostin C (0.1 microM), diminished cyclic strain-stimulated MCP-1 mRNA expression. Angiotensin II at 10 or 1,000 nM induced a moderate upregulation of MCP-1 mRNA, and no synergistic effects were observed between angiotensin II and cyclic strain. These results indicate that cyclic strain stimulates MCP-1 mRNA expression in smooth muscle cells through signaling pathway(s) mediated by tyrosine kinase activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / pharmacology
  • Animals
  • Arteriosclerosis / etiology
  • Cell Movement
  • Cells, Cultured
  • Chemokine CCL2 / genetics*
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • Gene Expression / drug effects
  • Monocytes / physiology
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / metabolism*
  • Naphthalenes / pharmacology
  • Phosphotyrosine / metabolism
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / metabolism
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • RNA, Messenger / genetics*
  • RNA, Messenger / metabolism*
  • Rats
  • Stress, Mechanical

Substances

  • Chemokine CCL2
  • Enzyme Inhibitors
  • Naphthalenes
  • RNA, Messenger
  • Angiotensin II
  • Phosphotyrosine
  • Protein-Tyrosine Kinases
  • Protein Kinase C
  • calphostin C